These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13583625)

  • 1. Sublingual heparin in hyperlipemia; a preliminary report.
    FULLER HL
    Angiology; 1958 Oct; 9(5):311-3. PubMed ID: 13583625
    [No Abstract]   [Full Text] [Related]  

  • 2. Essential hyperlipemia treated with heparin and with chlorpromazine.
    HOLLISTER LE; KANTER SL
    Gastroenterology; 1955 Dec; 29(6):1069-76. PubMed ID: 13270832
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged observations of the cardiovascular status in essential hyperlipemia; with special reference to serum lipid response to heparin.
    SOFFER A; MURRAY M
    Circulation; 1954 Aug; 10(2):255-64. PubMed ID: 13182759
    [No Abstract]   [Full Text] [Related]  

  • 4. Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. V. Analysis of serum lipoproteins by means of ultracentrifuge before and after administration of heparin.
    LEVER WF; HERBST FS; LYONS ME
    AMA Arch Derm; 1955 Feb; 71(2):158-71. PubMed ID: 13227606
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparin test in hyperlipemia and its practical value].
    BINAK K; HARMANCI N
    Turk Tip Cemiy Mecm; 1961 Oct; 27():499-507. PubMed ID: 13869229
    [No Abstract]   [Full Text] [Related]  

  • 6. Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. III. Effects of intravenously administered heparin on the plasma proteins and lipids.
    LEVER WF; SMITH PA; HURLEY NA
    J Invest Dermatol; 1954 Jan; 22(1):71-84; discussion, 84-7. PubMed ID: 13118255
    [No Abstract]   [Full Text] [Related]  

  • 7. Rebound hyperlipemia following intravenous heparin.
    WOLDOW A; WOLF HL
    Am J Cardiol; 1960 Dec; 6():1036-41. PubMed ID: 13786247
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of heparin on alimentary hyperlipemia. Two-dimensional electrochromatographic study.
    BENAS A; KELER-BACOKA M; PUCAR Z
    Arch Biochem Biophys; 1962 Feb; 96():434-7. PubMed ID: 13867025
    [No Abstract]   [Full Text] [Related]  

  • 9. The clearing by heparin of alimentary lipaemia in coronary artery disease.
    OLIVER MF; BOYD GS
    Clin Sci; 1953; 12(3):293-8. PubMed ID: 13082751
    [No Abstract]   [Full Text] [Related]  

  • 10. EFFECT OF MULTIPLE INJECTIONS OF HEPARIN ON THE HYPERLIPEMIA OF ATHEROSCLEROSIS.
    WOLDOW A; LOPEZ RH; GOLDBERG H
    Am J Cardiol; 1964 Jul; 14():64-8. PubMed ID: 14176893
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of heparin on plasma lipid partition in man: studies in normal persons and in patients with coronary atherosclerosis, nephrosis and primary hyperlipemia.
    HERZSTEIN J; WANG CI; ALDERSBERG D
    Ann Intern Med; 1954 Feb; 40(2):290-305. PubMed ID: 13125213
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of hyperlipemia & certain clearing factors on erythrosedimentation rate in autoplasma & in pectin in atherosclerotic subjects].
    RULLI V; ROSSI B
    Gazz Med Ital; 1959 May; 118(5):207-10. PubMed ID: 13664061
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of sublingual heparin on lipemia clearing and on recurrence of myocardial infarction.
    FULLER HL
    Angiology; 1960 Jun; 11():200-6. PubMed ID: 13825618
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipemia in patients with coronary heart disease.
    KUO PT
    J Am Diet Assoc; 1957 Jan; 33(1):22-5. PubMed ID: 13385086
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparin, lipoprotein lipase and plasma lipids].
    Hollmann M
    Dtsch Med J; 1968 Apr; 19(8):270-8. PubMed ID: 4891142
    [No Abstract]   [Full Text] [Related]  

  • 16. [Trial therapy in essential hyperlipemia].
    BENGTSSON E
    Nord Med; 1955 Sep; 54(36):1388-9. PubMed ID: 13266136
    [No Abstract]   [Full Text] [Related]  

  • 17. USE OF heparin sodium in hyperlipemia.
    J Am Med Assoc; 1958 Jan; 166(1):52-3. PubMed ID: 13491314
    [No Abstract]   [Full Text] [Related]  

  • 18. [Research on experimental hyperlipemia. IV. Effects of heparin on the inhibitor of the clarifying factor].
    Jouzier E; Tixier M; Tayeau F
    Bord Med; 1970 Sep; 3(9):2017-20. PubMed ID: 5481185
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the influenceability of serum lipids in essential hyperlipemia].
    JAHNKE K; SCHILD W
    Arztl Wochensch; 1958 Jun; 13(26):572-5. PubMed ID: 13559068
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of multiple injections of heparin on the hyperlipemia of atherosclerosis. Preliminary report.
    WOLDOW A; LOPEZ RH; GOLDBERG H
    J Albert Einstein Med Cent (Phila); 1962 Apr; 10():68-72. PubMed ID: 14007910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.